G

GlyProVac LLC

7 employees

GlyProVac is pursuing the development of a glycoprotein based vaccine against Enterotoxigenic Escherichia coli (ETEC).

Basic info

Industry

biotechnology research

Sectors

Bacterial Pathogens
Molecular Biology
Microbiology
Mass Spectrometry
Biopharma

Date founded

2018

FAQ